Details, Explanation and Meaning About Amoxicillin

Amoxicillin Guide, Meaning , Facts, Information and Description


Amoxicillin
(2S,5R,6R)-6-[(R)-2-amino-2-(4-hydroxyphenyl)
acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo
[3.2.0] heptane-2-carboxylic acid
Empirical formula C16H19N3O5S
Molecular weight 365.4
Half life 61.3 minutes
Excretion renal
Pregnancy category A (Australia)

Amoxicillin (formerly amoxycillin in the British Pharmacopoeia) is a moderate-spectrum β-lactam antibiotic; used to treat bacterial infections caused by susceptible microorganisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other beta-lactam antibiotics. Amoxicillin is susceptible to degradation by β-lactamase;-producing bacteria, and so is often given clavulanic acid (see below). It is currently marketed by GlaxoSmithKline under the trade name Amoxil®.

Mode of action

Amoxicillin acts by inhibiting the synthesis of bacterial cell walls. It inhibits cross-linkage between the linear peptidoglycan polymer chains that make up a major component of the cell wall of Gram-positive bacteria.

Main article: beta-lactam antibiotic

Microbiology

Amoxicillin is a moderate-spectrum antibiotic active against a wide range of Gram-positive, and a limited range of Gram-negative organisms. Some examples of susceptible and resistant organisms, from the Amoxil® Approved Product Information (GSK, 2003), are listed below.

Susceptible Gram-positive organisms

Streptococcus spp., Diplococcus pneumoniae, non β-lactamase;-producing Staphylococcus spp., and Streptococcus faecalis.

Susceptible Gram-negative organisms

Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Escherichia coli, Proteus mirabilis and Salmonella spp.

Resistant organisms

Penicillinase producing organisms, particularly penicillinase producing Staphylococcus spp. Penicillinase-producing N. gonorrhoeae and H. influenzae are also resistant

All strains of Pseudomonas spp., Klebsiella spp., Enterobacter spp., indole-positive Proteus spp., Serratia marcescens, and Citrobacter spp. are resistant.

The incidence of β-lactamase-producing resistant organisms, including E. coli, appears to be increasing.

Amoxicillin and Clavulanic acid

Amoxicillin is sometimes combined with clavulanic acid, a β-lactamase inhibitor, to increase the spectrum of action against Gram-negative organisms, and to overcome bacterial antibiotic resistance mediated through β-lactamase production. This formulation is referred to as co-amoxiclav (British Approved Name), but more commonly by proprietary names such as Augmentin® and Clamoxyl®.

Main article: co-amoxiclav

Proprietary Preparations

The patent for amoxicillin has expired. Thus amoxicillin is marketed under many trade names including: Actimoxi®, Amoxibiotic®, Amoxicilina®, Pamoxicillin®, Lamoxy®, Polymox®, Trimox® and Zimox®.

References

  • GlaxoSmithKline Australia Pty Ltd (2003). Amoxil® Approved Product Information. Boronia: GlaxoSmithKline.
  • Neal, MJ (2002). Medical Pharmacology at a Glance (4 ed.). Oxford: Blackwell Science. ISBN 0-632-05244-9


This is an Article on Amoxicillin. Page Contains Information, Facts Details or Explanation Guide About Amoxicillin


Google
 
Web www.E-paranoids.com

Search Anything